KCNH1 and cervical cancer: In turn, in an experimental study by the team of de Guadalupe Chávez-López [186], antiproliferative and proapoptotic effects of astemizole were demonstrated in cervical cancer cell lines of different HPV status (CaSki, SiHa, HeLa, INBL and C-33A) with a pronounced expression of Eag1 channels involved in tumor progression and it was suggested that astemizole is an alternative therapeutic option in the treatment of cervical cancer by targeting potassium channels.